Please forward the announcement below to your network of clinical and basic researchers. Due date for nominations is April 29, 2022
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) in partnership with ALS Finding a Cure® (ALSFAC) and FightMND is issuing a request for applications for the ALS Scholars in Therapeutics Program to empower young investigators to learn how to develop new treatments for people living with ALS. Full announcement can be found here.
This two-year program is designed to engage clinician-scientists and post-doctoral fellows to gain training and experience in therapy development for ALS at their home institution with an optional industry experience in year two. All ALS Scholars will be part of the broader ALS global community. We believe strongly in identifying, supporting, and mentoring the next generation of researchers and are continuing this tradition through the ALS Scholars in Therapeutics Program.
ALS Scholars will be an integral member of the Healey & AMG Center for ALS at Mass General and will benefit from mentorship by world renowned scientists and clinicians. While working closely with their mentors at their home institution, the Scholars will also attend Healey Center and ALSFAC meetings and learn first-hand current approaches to therapy development. Importantly, Scholars will have the opportunity to engage directly with people living with ALS. In addition, successful candidates interested in understanding the drug development process from an industry perspective, will benefit from an optional six-month internship in industry during the second year of their scholarship.
Meet the 2021 Scholars here.
- 2 years of funding to support a clinician-scientist or post-doctoral fellow working in the ALS field anywhere in the world.
- $150,000 award/funding year
- Recipient must commit at least 75% effort to the proposed ALS research plan
- Applications from clinician scientists and postdoctoral fellows focused on translational research.
- Candidates with Ph.D. or M.D. with strong publication record. International applicants are encouraged to apply.
- The ALS focused proposal must have a strong scientific rationale and should be largely developed by the fellow with guidance from his/her mentor.
- Eligibility for this award is based on the date the candidate attained their degree/qualification. For MDs, scholars will be considered if they have completed their specialist qualification (i.e., US Residency; Fellowship of the Royal Australasian College of Physicians, etc.) For PhDs, they can be no more than 5 years post-degree.
Release of RFA: March 2, 2022
Applications Due: April 29, 2022
Notification of Award: June 2022
Initiation of Award*: July 1, 2022 (flexible once contracts signed)
*Note: Once the award has been finalized the Healey Center for ALS will work with the successful candidate to secure an industry internship in the second year of the fellowship.